Closamectin (5 mg + 200 mg)/ml Roztwór do polewania Пољска - Пољски - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

closamectin (5 mg + 200 mg)/ml roztwór do polewania

norbrook laboratories (ireland) limited - closantelum + ivermectinum - roztwór do polewania - (5 mg + 200 mg)/ml - bydło

Adakveo Европска Унија - Пољски - EMA (European Medicines Agency)

adakveo

novartis europharm limited - crizanlizumab - anemia, sickle cell - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.